GlassScriptPhysician profile
Michael Joel Consolo
NPI 1699038034
$8,988.77
in general payments reported to CMS, 2019-2025
52 companies · $1,106 in 2025
The $1,106 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,770 · 2020: $720 · 2021: $1,009 · 2022: $1,501 · 2023: $1,815 · 2024: $1,069 · 2025: $1,106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,955 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,954.51 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,435.89 | 2019-2025 | Lupron Depot, Avycaz |
| Neotract INC. | $1,119.40 | 2019-2020 | |
| Janssen Biotech, INC. | $737.91 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $733.69 | 2019-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $441.97 | 2023-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $387.36 | 2021-2025 | Prolaris, Myrisk |
| Axonics, INC. | $324.23 | 2020-2024 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $304.89 | 2019-2024 | |
| Teleflex LLC | $278.12 | 2021-2024 | Urolift |
| Pfizer INC. | $267.93 | 2019-2025 | |
| Rochester Medical Corporation | $261.97 | 2022 | |
| Verity Pharmaceuticals INC. | $234.27 | 2022-2024 | Trelstar |
| Urovant Sciences INC | $185.90 | 2021-2022 | |
| Urogen Pharma, INC. | $174.36 | 2022-2025 | Jelmyto |
| C. R. Bard, INC. & Subsidiaries | $165.05 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $163.70 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Dendreon Pharmaceuticals LLC | $160.40 | 2019-2025 | Provenge |
| Biotissue Holdings INC. | $152.05 | 2023-2025 | |
| Telix Pharmaceuticals | $151.37 | 2024-2025 | Illuccix |
| Boston Scientific Corporation | $143.53 | 2019-2025 | Ams 700, Solyx Sis System, Rezum Generator |
| Myovant Sciences INC. | $139.65 | 2021-2022 | |
| Blue Earth Diagnostics | $106.04 | 2022-2023 | |
| Smith+Nephew, INC. | $94.09 | 2019-2023 | Stravix |
| Coloplast Corp | $73.15 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $58.68 | 2020 | |
| Endo Pharmaceuticals INC. | $56.56 | 2019-2023 | Xiaflex |
| Hollister Incorporated | $49.51 | 2021-2023 | Vapro Pocket |
| Antares Pharma, INC. | $42.76 | 2021-2023 | Xyosted, Tlando, Nocdurna |
| Calyxo, INC. | $40.00 | 2024-2025 | Cvac Aspiration System |
| Accord Healthcare, INC. | $36.25 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Integra Lifesciences Corporation | $32.10 | 2023 | Biofix, Biodoptix, Biodfactor |
| Karl Storz Endoscopy-America | $31.00 | 2020 | |
| Amniox Medical, INC. | $28.39 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $28.12 | 2025 | |
| Mallinckrodt Enterprises LLC | $27.84 | 2019 | |
| Sun Pharmaceutical Industries INC. | $23.66 | 2022 | |
| Progenics Pharmaceuticals, INC. | $23.35 | 2025 | |
| Immunitybio, INC. | $22.85 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $22.06 | 2023 | Seglentis |
| Ambu INC. | $20.76 | 2021 | |
| Angiodynamics, INC. | $20.27 | 2025 | Nanoknife |
| Osiris Therapeutics INC. | $19.88 | 2019 | |
| Allergan, INC. | $19.84 | 2021 | |
| Ferring Pharmaceuticals INC. | $19.44 | 2025 | Adstiladrin |
| Conmed Corporation | $19.18 | 2023 | Airseal |
| Avanos Medical | $17.22 | 2023 | On-Q* Pump and Accessories |
| Olympus America INC. | $16.02 | 2025 | Itind System |
| Duchesnay USA Incorporated | $15.32 | 2019 | |
| Procept Biorobotics Corporation | $13.62 | 2019 | |
| Cook Medical LLC | $12.11 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Consolo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.